| Coexistent familial nonmultiple endocrine neoplasia medullary thyroid carcinoma and papillary thyroid carcinoma associated with RET polymorphism. | thyroid, |
| Effects of silencing RET/PTC1 junction oncogene in human papillary thyroid carcinoma cells. | thyroid, |
| A hereditary pattern [multiple endocrine neoplasia type 2 (MEN 2)] is present in 20-30% of Medullary thyroid carcinoma cases, transmitted as an autosomal-dominant trait due to germline mutations of the RET proto-oncogene. | thyroid, |
| A study of RET proto-oncogene polymorphisms in association with lung cancer risk in the Korean population. | lung, |
| Single nucleotide polymorphisms may function as modifiers of the RET proto-oncogene, resulting in the expression of medullary thyroid carcinoma and papillary thyroid carcinoma. | thyroid, |
| Single nucleotide polymorphisms act as modifiers and correlate with the development of medullary and simultaneous medullary/papillary thyroid carcinomas in 2 large, non-related families with the RET V804M proto-oncogene mutation. | thyroid, |
| Preventive thyroidectomy in patients with hereditary medullary thyroid carcinoma found heterozygote for mutant RET proto-oncogene. | thyroid, |
| Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. | thyroid, |
| Indolent medullary thyroid cancer with a RET proto-oncogene Cys618Phe mutation presenting as sporadic unilateral pheochromocytoma in a 55-year-old Korean woman. | PCPG,thyroid, |
| Molecular analysis of the RET proto-oncogene key exons in patients with medullary thyroid carcinoma: a comprehensive study of the Iranian population. | thyroid, |
| Mutations of RET proto-oncogene in hereditary medullary thyroid carcinoma in Iranian population | thyroid, |
| The aim of this study was to evaluate if germline variants of the RET protooncogene are associated with glioblastoma multiforme, pancreatic cancer and gastric cancer. | pancreatic,gastric,glioblastoma, |
| RET-protooncogene variants in patients with sporadic neoplasms of the digestive tract and the central nervous system. | neoplasm, |
| Mutational analysis of RET proto-oncogene among patients with medullary thyroid carcinoma and at risk carriers from India. | thyroid, |
| the mutational profile of RET proto-oncogene in medullary thyroid carcinoma in the Indian population | thyroid, |
| RET proto-oncogene variants Arg886Trp and Glu511Lys are associated with thyroid neoplasms. | neoplasm,thyroid, |
| Recombinant ret oncogene products induce T-lymphocyte proliferation, and suppress lymphoma derived from ret transgenic mice. | lymphoma, |
| Interplay between Ret and Fap-1 regulates CD95-mediated apoptosis in medullary thyroid cancer cells. | thyroid, |
| In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer. | thyroid, |
| Hirschsprung s disease and medullary thyroid carcinoma: 15-year experience with molecular genetic screening of the RET proto-oncogene. | thyroid, |